Press Releases
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 37–48 of 212 articles
Vanda Pharmaceuticals Launches NEREUS (Tradipitant) - First New Motion Sickness Drug in 40+ Years Now Available
Novo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection
ZETA SURGICAL Receives FDA 510(k) Clearance for Brain Surgery Navigation System
Viatris Presents Six Studies on Low-Dose Estrogen Contraceptive Patch at ACOG 2026
Axsome Therapeutics Receives FDA Approval for AUVELITY to Treat Alzheimer's Agitation - First-in-Class Breakthrough
MRM Health's MH002 Receives FDA Fast Track Designation for Ulcerative Colitis Treatment
Cadrenal Therapeutics CAD-1005 Gets FDA Guidance for Phase 3 Trial in Heparin-Induced Thrombocytopenia
RedHill's RHB-204 Shows Comparable Efficacy to RHB-104 in Crohn's Disease MAP Treatment Development
AC Immune Advances ACI-24 Alzheimer's Trial to Final Cohort, Initiates ACI-19764 Phase 1 Study
Addex Advances Dipraglurant for Brain Injury Recovery, Reports 2025 Financial Results
AC Immune Initiates Final Cohort in Phase 1b/2 ABATE Trial for Anti-Abeta Alzheimer's Treatment
Mabwell 9MW2821 Cervical Cancer Data to Be Presented at ESMO GC 2026 Conference